RGEN
- Repligen Corporation
()
Overview
Company Summary
Repligen Corporation (RGEN) is a leading bioprocessing company that specializes in the development and manufacturing of products used in the production of biological drugs.
The company provides a wide range of products and technologies that are essential for the manufacturing processes of biologic drugs, including monoclonal antibodies, vaccines, gene therapies, and other biologics. These products are used by pharmaceutical and biotechnology companies, contract development and manufacturing organizations (CDMOs), and academic institutions worldwide.
Repligen's key product line is its Protein A affinity ligands, which are employed in the purification of monoclonal antibodies and other therapeutic proteins. These ligands help in the removal of impurities and contaminants, ensuring the quality, purity, and safety of the final drug product.
Additionally, Repligen offers a variety of filtration products, such as hollow fiber filters and chromatography columns, which are used in downstream processing to further purify and separate biologic molecules.
The company also provides pre-packed chromatography columns, filtration systems, and other consumables used in bioprocessing operations. These products enable biopharmaceutical manufacturers to optimize their production processes, increase efficiency, and reduce time-to-market for their drugs.
Repligen is dedicated to continuously innovating and advancing its product offerings to meet the evolving needs of the biopharmaceutical industry. It invests in research and development to develop new technologies and improve existing products, ensuring that its customers have access to state-of-the-art solutions.
In summary, Repligen Corporation plays a crucial role in the biopharmaceutical industry by supplying essential products and technologies that support the efficient and effective production of biologic drugs. Its expertise in bioprocessing helps pharmaceutical companies and research institutions advance their drug development and manufacturing processes, ultimately leading to improved patient outcomes.